ema semaglutide naion june 2025 Novo Nordisk refutes link between Wegovy and eye disease Government Agency Confirms NAION Risk

Ravna AW et al (2009): Structure and localisation of drug binding sites on neurotransmitter transporters

FDA-approved alternatives to Mounjaro include Wegovy and Ozempic, offering 9-15% body weight reduction through verified clinical trials

The path to a healthier, more vibrant you is just a click away

Although currently FDA-approved for diabetes and weight management, clinical evidence indicates these medications also interact with the brains neurological reward pathways involved in substance use disorder

The documented range is 13 times per day

Many clinicians actively recommend PPI therapy for semaglutide users with significant reflux symptoms